Study: Daily aspirin could be a killer for some, rather than a cure

Daily aspirin could be a killer for some, rather than a cure, according to a new study.

Research shows the risk of internal bleeding in healthy people may be greater than any potential benefit, such as preventing heart disease.

One of the report's authors, Dr. Trevor Thompson of the University of Greenwich, said: "Aspirin is good if you've been identified as at risk of cardiovascular problems. If not, the risks outweigh any potential benefits. Our analysis found a much-increased risk of bleeding on the brain or in the stomach, which could be fatal."

The review of existing research has been published in the British Journal of Clinical Pharmacology.

It looked at 67 different reviews and found that a small dose (less than 325milligrams a day, roughly one tablet) for people without cardiovascular disease was associated with a 17% lower incidence of cardiovascular problems, such as heart attack or stroke.

In contrast, there was also a 47% higher risk of gastrointestinal bleeding and a 34% higher risk of bleeding in the skull.

This is something that people may be doing every day that can cause unnecessary harm. Our study shows that an aspirin a day should only be taken by people who have a cardiovascular condition or have been told by a doctor that they are in danger of developing one."

Dr. Trevor Thompson, Study Author, University of Greenwich

The report also looked at research that said aspirin could help prevent cancer but found the risks again outweighed the benefits.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Xylitol linked to higher risk of cardiovascular events, Cleveland Clinic study finds